Australia markets open in 9 hours 57 minutes

Encompass Health Corporation (EHC)

NYSE - Nasdaq Real-time price. Currency in USD
Add to watchlist
52.99-0.34 (-0.64%)
As of 10:03AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 5.37B
Enterprise value 8.72B
Trailing P/E 16.47
Forward P/E 14.20
PEG ratio (5-yr expected) N/A
Price/sales (ttm)1.02
Price/book (mrq)2.68
Enterprise value/revenue 1.66
Enterprise value/EBITDA 8.80

Trading information

Stock price history

Beta (5Y monthly) 0.91
52-week change 3-13.17%
S&P500 52-week change 3-2.16%
52-week high 364.80
52-week low 342.19
50-day moving average 348.53
200-day moving average 351.13

Share statistics

Avg vol (3-month) 31.02M
Avg vol (10-day) 31.1M
Shares outstanding 599.78M
Implied shares outstanding 6N/A
Float 897.77M
% held by insiders 12.04%
% held by institutions 196.88%
Shares short (28 July 2022) 42.42M
Short ratio (28 July 2022) 43
Short % of float (28 July 2022) 43.17%
Short % of shares outstanding (28 July 2022) 42.43%
Shares short (prior month 29 June 2022) 42.31M

Dividends & splits

Forward annual dividend rate 40.6
Forward annual dividend yield 41.11%
Trailing annual dividend rate 31.12
Trailing annual dividend yield 32.10%
5-year average dividend yield 41.65
Payout ratio 425.69%
Dividend date 316 Oct 2022
Ex-dividend date 429 Sept 2022
Last split factor 21257:1000
Last split date 330 June 2022

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2021
Most-recent quarter (mrq)29 June 2022


Profit margin 6.22%
Operating margin (ttm)13.78%

Management effectiveness

Return on assets (ttm)6.62%
Return on equity (ttm)17.83%

Income statement

Revenue (ttm)5.27B
Revenue per share (ttm)53.15
Quarterly revenue growth (yoy)3.30%
Gross profit (ttm)2.03B
Net income avi to common (ttm)326.6M
Diluted EPS (ttm)3.27
Quarterly earnings growth (yoy)-57.00%

Balance sheet

Total cash (mrq)186.5M
Total cash per share (mrq)1.87
Total debt (mrq)3.53B
Total debt/equity (mrq)138.78
Current ratio (mrq)1.24
Book value per share (mrq)20.07

Cash flow statement

Operating cash flow (ttm)764.9M
Levered free cash flow (ttm)79.4M